XML 32 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows
$ in Millions
 6 Months Ended
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
OPERATING ACTIVITIES:    
Net income $ 239 $ 170
Adjustments to net income:    
Depreciation and amortization 620 550
Gain (loss) on disposal and sale of business interests (44) 4
Impairment expense 276 199
Deferred income tax expense (benefit) 181 (119)
Emissions Allowance Expense 71 139
Loss on realized/unrealized foreign currency 78 71
Other (27) 91
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (239) 60
(Increase) decrease in inventory 31 276
(Increase) decrease in prepaid expenses and other current assets 133 71
(Increase) decrease in other assets 47 74
Increase (decrease) in accounts payable and other current liabilities (160) (305)
Increase (decrease) in income tax payables, net and other tax payables (464) (85)
Increase (decrease) in other liabilities 74 (47)
Net cash provided by operating activities 679 1,187
INVESTING ACTIVITIES:    
Capital expenditures (3,833) (3,396)
Payments to Acquire Businesses and Interest in Affiliates 73 290
Proceeds from Divestiture of Businesses and Interests in Affiliates 11 98
Sale of short-term investments 534 706
Purchase of short-term investments (604) (620)
Contributions and loans to equity affiliates (50) (112)
Payments to Acquire Intangible Assets (91) (115)
Other investing (118) (21)
Net cash used in investing activities (4,224) (3,750)
FINANCING ACTIVITIES:    
Borrowings under the revolving credit facilities 4,003 2,521
Repayments under the revolving credit facilities (2,582) (2,131)
Proceeds from (Repayments of) Commercial Paper 690 517
Issuance of recourse debt 950 1,400
Issuance of non-recourse debt 3,798 1,457
Repayments of non-recourse debt (2,726) (944)
Payments for financing fees (75) (67)
Purchases under supplier financing arrangements (708) (818)
Repayments of obligations under supplier financing arrangements 1,055 862
Distributions to noncontrolling interests (128) (147)
Contributions from noncontrolling interests 97 18
Sales to Noncontrolling Interests 323 189
Dividends paid on AES common stock (238) (222)
Payments for financed capital expenditures (19) (7)
Other financing 13 (11)
Net cash provided by financing activities 3,759 2,529
Effect of exchange rate changes on cash, cash equivalents and restricted cash (43) (37)
Net Cash Change Of Discontinued And Held For Sale Businesses (13) (6)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 158 (77)
Cash, cash equivalents and restricted cash, beginning 1,990 2,087
Cash, cash equivalents and restricted cash, ending 2,148 2,010
SUPPLEMENTAL DISCLOSURES:    
Cash payments for interest, net of amounts capitalized 765 512
Cash payments for income taxes, net of refunds 209 200
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:    
Noncash or Part Noncash Divestiture, Amount of Consideration Received 14 218
Lease Obligation Incurred 180 82
Conversion of Stock, Amount Converted 838 0
Liability derecognized due to sale of assets 273  
Non-cash contributions from noncontrolling interests 25 30
Other current assets, net of allowance of $0 and $14, respectively 1,458  
Loss (gain) on realized/unrealized derivatives (137) $ 38
Warrior Run    
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:    
Liability derecognized due to sale of assets $ 260